100
Participants
Start Date
October 31, 2014
Primary Completion Date
July 31, 2015
Study Completion Date
July 31, 2015
Simethicone
"Pharmacological category: antiflatulent~160mg Simethicone orally, 4 times a day for the first five postoperative days"
Oral Suspending Vehicle
"ORA-Plus is an aqueous-based vehicle.~Identical to the test drug formulation except for being pharmacologically inert. 160mg Ora-Plus orally, 4 times a day for the first five postoperative days"
St. Joseph's Healthcare Hamilton, Hamilton
Juravinski Hospital, Hamilton
Collaborators (1)
McMaster Surgical Associates
OTHER
McMaster University
OTHER